Skip to main content Scroll Top

News

  • Home
  • Alzheimer
  • A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance
Most Viewed Posts
Clear Filters
REGEnLIFE cures inflammatory brain diseases with light
Brain photobiomodulation: a potential treatment in Alzheimer’s and Parkinson’s diseases
Boost Invest MedVallée: a decisive springboard for Montpellier’s global healthcare startups

A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance

Blivet G, Relano-Gines A, Wachtel M, Touchon J.

J Alzheimers Dis. 2022;90(2):811-822. doi: 10.3233/JAD-220467.

PMID: 36189591 Clinical Trial.

Share this article